Direct Peroral Cholangioscopy by Using an Ultra-slim Upper Endoscope
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02276157 |
Recruitment Status : Unknown
Verified April 2016 by Jong Ho Moon, Soonchunhyang University Hospital.
Recruitment status was: Enrolling by invitation
First Posted : October 28, 2014
Last Update Posted : April 20, 2016
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Bile Duct Stricture Choledocholithiasis |
Study Type : | Observational |
Estimated Enrollment : | 300 participants |
Observational Model: | Cohort |
Time Perspective: | Retrospective |
Official Title: | Direct Peroral Cholangioscopy by Using an Ultra-slim Upper Endoscope |
Study Start Date : | August 2006 |
Estimated Primary Completion Date : | April 2016 |
Estimated Study Completion Date : | December 2016 |
Group/Cohort |
---|
Direct peroral cholangioscopy
Patients with bile duct disease that is eligible to direct peroral cholangioscopy
|
- Success rate [ Time Frame: Within 24 hours after Completion of DPOC ]Advance of an ultra-slim endoscope into the hilar portion or stricture
- Diagnostic accuracy [ Time Frame: Up to 10 days after completion of DPOC ]Diagnostic accuracy for bile duct diseases
- Success rate of therapeutic procedures under DPOC [ Time Frame: Within 24 hours after Completion of DPOC ]Maintenance of the endoscope position until the successful therapy under DPOC
- Complication [ Time Frame: Within 30 days after DPOC ]cholangitis, pancreatitis, hemobilia, perforation, air embolism or mortality

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Patients with bile duct diseases
- Dilated common bile duct (> 8mm)
- Having previous sphincteroplasty by endoscopic sphincterotomy and/or papillary balloon dilation
Exclusion Criteria:
- Periampullary malignancies
- Severe stricture on papillary orifice
- Bleeding tendency
- Contraindications for endoscopic retrograde cholangiopancreatography

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02276157
Korea, Republic of | |
Soonchunhyang University Bucheon Hospital | |
Bucheon, Korea, Republic of, 420-767 |
Principal Investigator: | Jong Ho Moon, M.D., Ph.D. | SoonChunHyang University School of Medicine |
Other Publications:
Responsible Party: | Jong Ho Moon, Professor, Soonchunhyang University Hospital |
ClinicalTrials.gov Identifier: | NCT02276157 |
Other Study ID Numbers: |
2014-07-026 |
First Posted: | October 28, 2014 Key Record Dates |
Last Update Posted: | April 20, 2016 |
Last Verified: | April 2016 |
cholangioscopy |
Choledocholithiasis Common Bile Duct Diseases Bile Duct Diseases |
Biliary Tract Diseases Digestive System Diseases Cholelithiasis |